Peter J Wilkinson

CIK 1398138 · SVP, Chief Accounting Officer · last filed 2026-03-30

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$927.6K

Companies

2

Total Filings

47

Lifetime Open-Market Net

-$3.59M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
LH	SVP, Chief Accounting Officer	3,485	$266.16	$927.6K	-$3.29M	37	2026-03-30
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted	VP of Fin./Chief Acctg. Off.	828	—	—	-$299.5K	10	2009-01-05

Recent Filings · Page 3 of 5

47 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2023-02-14	LH	Mixed	+72	-$9.4K	EDGAR
2023-02-09	LH	Grant (A)	—	$0	EDGAR
2023-02-07	LH	Mixed	+98	-$12.7K	EDGAR
2023-02-06	LH	Mixed	+76	-$10.5K	EDGAR
2022-08-03	LH	Mixed	−1,782	-$559.1K	EDGAR
2022-03-29	LH	Mixed	+1,907	-$252.9K	EDGAR
2022-02-15	LH	Mixed	+606	-$71.2K	EDGAR
2022-02-08	LH	Mixed	+97	-$14.7K	EDGAR
2022-02-04	LH	Mixed	+75	-$11.2K	EDGAR
2021-08-03	LH	Mixed	+35	-$4.5K	EDGAR

Showing 21–30 of 47

Prev Page 3 of 5 Next

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.